ATIN: Net sales grew but operating losses widened in Q2 2025, driven by negative securities value changes

About this update from Athanase Innovation Ab

Q2 2025 saw net sales rise to SEK 5.4m, but operating losses deepened to SEK -27.2m, with negative value changes in securities. Ivisys drove all sales, while Flyttsmart and Lifesum showed strong growth amid challenging market conditions.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Athanase Innovation Ab